Commission approves reciprocity candidates, resident and nonresident pharmacy applications and nonsterile compounding requests

Connecticut Commission of Pharmacy ยท November 5, 2025

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Connecticut Commission of Pharmacy approved nine reciprocity candidates, multiple resident and nonresident pharmacy applications, and nonsterile compounding permissions for nonresident firms (with one applicant approved only for nonsterile pending additional documentation). Approvals were taken by voice vote.

The Commission moved and approved a series of licensing motions during the meeting. Commissioner Kristen Linder moved to process nine reciprocity candidates; the motion was seconded and approved by voice vote. The record shows the motion as "so moved" followed by a voice vote; no roll-call tallies were recorded in the transcript.

The Commission then considered resident pharmacy applications and approved them by voice vote after a motion and second. Board staff reported some nonresident pharmacy applications had aged beyond acceptable timelines; applicants whose files had lapsed were instructed to reapply and pay the fee again. Several nonresident applications were approved after staff confirmed inspections and information from other boards, including a Texas Board of Pharmacy confirmation and NABP inspection documents for the applicants noted in the packet.

On nonresident compounding, the Commission approved at least one nonresident's nonsterile compounding application (Honeybee Health) where the required inspection reports were on file. One applicant, identified as HRX in the meeting, requested both sterile and nonsterile compounding; staff reported the applicant provided nonsterile documentation but still owed sterile-compounding documentation ("797"), so the board approved nonsterile compounding only and left sterile compounding pending submission of the outstanding documents. All licensing motions were disclosed in the meeting transcript as passed by voice vote; no individual recorded roll-call tallies or named vote counts were provided in the public record excerpt.